ERBB2 and breast cancer: Previous studies demonstrated that CXCL1 was closely correlated with clinical features of multiple malignancies, including poor prognosis, metastasis, reduced survival, and advanced TNM stage, as well as ER, PR, and HER2 status in BC [48].